Reach more patients faster with our clinical trial services
With a Europe-wide clinical team and distribution network, Sciensus’ clinical trial services will help you bring patients onto trial faster, retain them for longer and improve cost efficiency and data collection.
Introduction
Sciensus has a rich history of clinical trial services which help pharma, biotechs and NHS move products through to commercialisation. We have strong relationships with more than 50 pharma companies and have worked to develop a sophisticated decentralised clinical trials function that can operate directly with patients in their own homes right across Europe.
Sciensus’ unique clinical trials proposition
Sciensus offers a comprehensive clinical trial service, supporting Phase II to IV studies, insight research and early access schemes. With a Europe-wide clinical team, we provide a unique decentralised trial proposition that brings patients onto trials faster and retains them through a range of personalised support services. Many of the studies we support achieve 90% retention or above.
Our specially trained nurses can offer support both in a patient’s home and remotely, including administering investigational medicinal products (IMPs) and placebos, patient monitoring, sample collection and consenting. Additionally, our nurses can attend clinics to aid patient recruitment.
Supporting patients on clinical trials. Every step of the way.
Through our expert pharmacy services, we cover everything from storage, trial file management, randomisation temperature-controlled dispensing and supply from ambient, fridge, frozen and down to -90°C. Our resilient and well-established distribution network covers the whole of Europe, enabling you to widen the geographical reach of your study.
With the latest digital solutions and expertise in other areas such as cash management, data production, remote monitoring and regulatory compliance, we can also help you improve data collection and patient persistence and adherence to protocols.
GDP-compliant distribution
Innovative customisable end-to-end solution
Established European network
Meet our expert
Chris Appleby, Business Development Director – Specialist Services
Chris joined Sciensus in 2011 as a Cancer Pharmacist, following four years in the NHS. He led the Cancer Pharmacy, overseeing compounding and clinical trials, before serving as Chief Pharmacist for six years. During this time, he helped establish our Medical Advisory Committee and led the construction of our aseptic compounding unit.
In 2022, Chris became Business Development Director – Specialist Services, focusing on new propositions such as clinical trials and direct-to-hospital compounding. His initiatives include developing Sciensus’ commercial compounding services, collaborating with hospitals and expanding our portfolio. Chris has also completed an MBA and continues to drive growth in cancer care and specialised patient pathways.
Request more information
If you want to learn more about our clinical trial services, get in touch with our team.